{"id":"onabotulinumtoxina-50-unt-botox-cosmetic","safety":{"commonSideEffects":[{"rate":"7–13%","effect":"Headache"},{"rate":"5–10%","effect":"Injection site pain or bruising"},{"rate":"1–3%","effect":"Eyelid ptosis"},{"rate":"1–2%","effect":"Brow ptosis"},{"rate":"1–2%","effect":"Facial asymmetry"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The drug is a botulinum toxin serotype A that cleaves SNARE proteins required for acetylcholine vesicle release. This prevents muscle contraction in injected areas, smoothing facial wrinkles caused by repetitive muscle movement. The effect is temporary, typically lasting 3–4 months, after which neuromuscular function gradually recovers.","oneSentence":"OnabotulinumtoxinA blocks acetylcholine release at the neuromuscular junction, paralyzing muscles and reducing dynamic wrinkles.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:58:22.794Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Temporary improvement of moderate to severe glabellar lines (frown lines) in adults"},{"name":"Temporary improvement of moderate to severe lateral canthal lines (crow's feet) in adults"},{"name":"Temporary improvement of moderate to severe forehead lines in adults"}]},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Botox Cosmetic"],"phase":"marketed","status":"active","brandName":"OnabotulinumtoxinA 50 UNT [Botox Cosmetic]","genericName":"OnabotulinumtoxinA 50 UNT [Botox Cosmetic]","companyName":"Amir Moradi MD, MBA","companyId":"amir-moradi-md-mba","modality":"Small molecule","firstApprovalDate":"","aiSummary":"OnabotulinumtoxinA blocks acetylcholine release at the neuromuscular junction, paralyzing muscles and reducing dynamic wrinkles. Used for Temporary improvement of moderate to severe glabellar lines (frown lines) in adults, Temporary improvement of moderate to severe lateral canthal lines (crow's feet) in adults, Temporary improvement of moderate to severe forehead lines in adults.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":false,"score":3}}